This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Kaul, R. Articles by Binder, S. R. Search for Related Content PubMed PubMed Citation Articles by Kaul, R. Articles by Binder, S. R.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, December 2004, p. 5705-5709, Vol. 42, No. 12
0095-1137/04/$08.00+0     DOI: 10.1128/JCM.42.12.5705-5709.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.

Detection of Immunoglobulin M Antibodies Specific for Toxoplasma gondii with Increased Selectivity for Recently Acquired Infections

Clinical Diagnostics Group, Bio-Rad Laboratories, Hercules, California

Received 12 April 2004/ Returned for modification 26 July 2004/ Accepted 26 August 2004

Toxoplasma gondii infections can cause serious complications in pregnant women, leading to miscarriage, stillbirth, and birth defects. Definitive diagnosis of T. gondii acute infection is therefore critical for the clinical management of a mother and her fetus. Positive immunoglobulin M (IgM) results are not sufficient as evidence of recent infection, as these antibodies are often present for many months. Further, IgG avidity and differential agglutination tests, two tests used by reference laboratories to distinguish between recent and past infections, are not always in agreement, and both methods yield a significant number of indeterminate results. We report the development of a new toxoplasma IgM immunoassay that is performed by using a bead-based immunoassay on an automated analyzer (BioPlex 2200). Initial validation included 204 samples from pregnant women and 198 samples from asymptomatic healthy adults. An overall specificity of 99% was observed. Further, 100% sensitivity for acute infections was observed for 10 well-characterized seroconversion panels. We then examined 50 samples from pregnant women, all of which were IgM positive by ELISA, which had been fully evaluated in a reference laboratory. Of the 50 samples, 34 (68%) tested positive in the BioPlex 2200 toxoplasma IgM assay, of which 32 of 34 (94%) exhibited an acute or equivocal pattern by differential agglutination. Of the 16 negative samples, 15 (94%) showed high-IgG-avidity antibodies. Collectively, these results suggest that this new toxoplasma assay shows a preferential response to IgM antibodies produced by recent infections, reducing the number of positive results for pregnant women that will require extensive additional clinical evaluation.

This article has been cited by other articles:

• Calderaro, A., Piccolo, G., Peruzzi, S., Gorrini, C., Chezzi, C., Dettori, G. (2008). Evaluation of Toxoplasma gondii Immunoglobulin G (IgG) and IgM Assays Incorporating the New Vidia Analyzer System. CVI 15: 1076-1079 [Abstract] [Full Text]  
• Binder, S. R., Genovese, M. C., Merrill, J. T., Morris, R. I., Metzger, A. L. (2005). Computer-Assisted Pattern Recognition of Autoantibody Results. CVI 12: 1353-1357 [Abstract] [Full Text]